Effectiveness of Topical 0.5% Levofloxacin to Reduce the Conjunctival Bacterial Flora Before Intraocular Surgery

NCT00491049 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 140

Last updated 2007-06-25

No results posted yet for this study

Summary

The purpose of this study is to determine whether additional topical application of 0.5% levofloxacin is more effective in reducing the load of the conjunctival bacterial flora in patients scheduled for intraocular surgery than preoperative irrigation of the conjunctiva with povidone iodine alone.

Conditions

  • Conjunctival Bacterial Flora

Interventions

DRUG

0.5% levofloxacin eye drops

Sponsors & Collaborators

  • Santen Gmbh

    collaborator UNKNOWN
  • Ludwig-Maximilians - University of Munich

    lead OTHER

Principal Investigators

  • Herminia Mino de Kapsar, PhD · Augenklinik der LMU

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2004-09-30
Completion
2005-04-30

Countries

  • Germany

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00491049 on ClinicalTrials.gov